Avanir Pharmaceuticals is dedicated to the research and development of cutting-edge treatments and therapies for disorders of the central nervous system (CNS).
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site. To find out more, see our Cookie Policy and Privacy Policy